Hospira, Inc.

PEMETREXED (HOSPIRA)

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Hospira, Inc.

Pemetrexed (Hospira) HCPCS:

J9323

HCPCS Code Descriptor:

Injection, pemetrexed ditromethamine, 10 mg

Category:

J Code

Pemetrexed (Hospira) NDCs:

00409-2188-01, 00409-1045-01, 00409-3532-01, 00409-1060-01, 00409-1061-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Pemetrexed (Hospira) CPT Codes:

Potential CPT administration codes for Pemetrexed (Hospira) can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Pemetrexed (Hospira):

PEMETREXED (HOSPIRA) is a Oncology drug manufactured by Hospira, Inc. and administered via the Intravenous route of administration. The J Code: J9323 is aligned to the drug PEMETREXED (HOSPIRA).

ACCESS PRICING AND MORE BY REGISTERING

J9323 Added Date:

July 1, 2023

J9323 Effective Date:

July 1, 2023

J9323 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Pemetrexed (Hospira) billing and coding information.
Our team did not identify a source for Pemetrexed (Hospira) patient assistance information. Please reach out to our team if you feel that this is a mistake.
PEMETREXED (HOSPIRA) prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for PEMETREXED (HOSPIRA). Please check back in a few weeks.